Paloma Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-79,565
| Closed | -$307K | – | 1699 |
|
|
2018
Q2 | $307K | Buy |
79,565
+62,971
| +379% | +$243K | 0.01% | 967 |
|
|
2018
Q1 | $105K | Sell |
16,594
-11,566
| -41% | -$73.2K | ﹤0.01% | 1339 |
|
|
2017
Q4 | $227K | Buy |
+28,160
| New | +$227K | ﹤0.01% | 1082 |
|
|
2014
Q4 | – | Sell |
-2,392
| Closed | -$166K | – | 1374 |
|
|
2014
Q3 | $166K | Buy |
+2,392
| New | +$166K | 0.01% | 790 |
|
|
2013
Q3 | – | Sell |
-1,665
| Closed | -$88K | – | 1312 |
|
|
2013
Q2 | $88K | Buy |
+1,665
| New | +$88K | ﹤0.01% | 1049 |
|